Lisa Wiley, APRN
Nephrology · Kansas City, MONPI 1346005337
Payments from drug & device makers
Across 68 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$422
- Calliditas Therapeutics US Inc.$152
- Akebia Therapeutics Inc$95
- Novartis$91
- ANI Pharmaceuticals, Inc.$67
- Amgen$48
- plus $303 from 11 others
What the payments were for
- Food & beverage$1,178100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 33 | $422 |
| Calliditas Therapeutics US Inc. | 6 | $152 |
| Akebia Therapeutics Inc | 6 | $95 |
| Novartis | 3 | $91 |
| ANI Pharmaceuticals, Inc. | 3 | $67 |
| Amgen | 2 | $48 |
| GSK | 2 | $42 |
| Novo Nordisk | 2 | $40 |
| Boehringer Ingelheim | 2 | $40 |
| Scpharmaceuticals Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Mozarc Medical US LLC | 1 | $24 |
| Chiesi USA, Inc. | 1 | $23 |
| Bayer | 1 | $21 |
| Nxstage Medical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Fresenius USA Marketing, Inc. | 1 | $16 |
How this compares
$1,178 in reported general payments places this provider in the 55th percentile of 253 nephrology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nifedipine ErNifedipine | 14 | $535 |
| Potassium Chloride | 26 | $303 |
| Torsemide | 14 | $113 |
| Carvedilol | 19 | $90 |
| Losartan Potassium | 16 | $81 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Kansas City
- Ahmed AwadKansas City$12.4M
- Kelly AlfordKansas City$58K
- Tarek DarwishKansas City$52K
- Archana GoelKansas City$49K
- Richard CaplingKansas City$31K
- Thomas WiegmannKansas City$25K
- Jignesh ShahKansas City$7K
- Adnan KhanKansas City$7K
- Robert GolderKansas City$5K
- Benjamin HumphreysSaint Louis$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.